We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Resistance against Integrase Strand Transfer Inhibitors and Relevance to HIV Persistence.
- Authors
Mesplède, Thibault; Wainberg, Mark A.
- Abstract
Drug resistance prevents the successful treatment of HIV-positive individuals by decreasing viral sensitivity to a drug or a class of drugs. In addition to transmitted resistant viruses, treatment-naïve individuals can be confronted with the problem of drug resistance through de novo emergence of such variants. Resistant viruses have been reported for every antiretroviral drug tested so far, including the integrase strand transfer inhibitors raltegravir, elvitegravir and dolutegravir. However, de novo resistant variants against dolutegravir have been found in treatment-experienced but not in treatment-naïve individuals, a characteristic that is unique amongst antiretroviral drugs. We review here the issue of drug resistance against integrase strand transfer inhibitors as well as both pre-clinical and clinical studies that have led to the identification of the R263K mutation in integrase as a signature resistance substitution for dolutegravir. We also discuss how the topic of drug resistance against integrase strand transfer inhibitors may have relevance in regard to the nature of the HIV reservoir and possible HIV curative strategies.
- Subjects
DIAGNOSIS of HIV infections; INTEGRASE inhibitors; DRUG resistance; RALTEGRAVIR; MULTIDRUG-resistant HIV; ANTIRETROVIRAL agents; THERAPEUTICS
- Publication
Viruses (1999-4915), 2015, Vol 7, Issue 7, p3703
- ISSN
1999-4915
- Publication type
Article
- DOI
10.3390/v7072790